Colorectal cancer treatment and survival: The experience of major public hospitals in south australia over three decades

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2431-2440

  Roder, David ^a,f   Karapetis, Christos S ^b   Wattchow, David ^c   Moore, James ^d   Singhal, Nimit ^d   Joshi, Rohit ^e   Keefe, Dorothy ^d   Fusco, Kellie ^a   Powell, Kate ^f   Eckert, Marion ^g   Price, Timothy J ^e  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (United States)

^f SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^g CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

Author keywords

Clinical care; Colorectal cancer; Stage; Survival trends

Indexed keywords

ADULT; AGED; CANCER STAGING; COLORECTAL NEOPLASMS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PUBLIC HOSPITAL; REGISTER; SOUTH AUSTRALIA; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PUBLIC; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SOUTH AUSTRALIA; SURVIVAL RATE; TIME FACTORS;

EID: 84929193398     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2431     Document Type: Article

References (39)

1. (ABS) Australian Bureau of Statistics (1998). 1996 census of population and housing. Socio-economic indexes for areas, ABS, Canberra.
2. (AIHW & AACR) Australian Institute of Health and Welfare & Australasian Association of Cancer Registries (2001). Cancer survival in Australia. Part 2: statistical tables, Cancer Series, vol. 19 Cat. No. CAN14, Canberra.
3. (AIHW) Australian Institute of Health and Welfare (2012). Cancer survival and prevalence in Australia: period estimates from 1982 to 2010, cancer series No. 69. Cat. No. CAN 65, AIHW, Canberra.
4. (AIHW) Australian Institute of Health and Welfare (2013).Australian cancer incidence and mortality (ACIM) books, AIHW, Canberra.
5. Armitage P, Berry, G (eds.) (1987). Statistical Methods in Medical Research, Blackwell Scientific Publications, Oxford.
6. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee (2005). Guidelines for the prevention, early detection and management of colorectal cancer. Cancer Council Australia & Australian Cancer Network, Sydney.
7. Australian Health Technology Advisory Committee (1997). Colorectal cancer screening, Commonwealth Department of Health and Family Services, Canberra.
8. Beckmann KR, Bennett A, Young GP, et al (2014a). Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage. J Eval Clin Pract, 20, 467-77.
9. Beckmann KR, Roder DM, Hiller JE, et al (2014b). Influence of mammographic screening on breast cancer incidence trends in South Australia. Asian Pac J Cancer Prev, 15, 3105-12.
10. Bonett A, Roder D, Esterman A (1988). Cancer case-survival rates for South Australia: a comparison with US rates and a preliminary investigation of time trends. Med J Aust, 148, 556-9.
11. Cole SR, Tucker GR, Osborne JM, et al (2013). Shift to earlier stage at diagnosis as a consequence of the national bowel cancer screening program. Med J Aust, 198, 327-30.
12. Coleman MP, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38.
13. Department of Health & (AIHW) Australian Institute of Health and Welfare (2008). National bowel screening program monitoring report, Canberra, AIHW, Cancer Series 44. Cat. no. 40
14. Due SL, Wattchow DA, Sweeney JL, et al (2012). Colorectal cancer surgery 2000-2008: evaluation of a prospective database. ANZ J Surg, 82, 412-9.
15. Ferlay J, Soerjomataram I, Ervik M, et al (2013), Cancer incidence and mortality worldwide: IARC CancerBase No.11. Lyon, France: IARC .
16. Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7.
17. Hewitson P, Glasziou P, Watson E, et al (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol, 103, 1541-9.
18. Howlader N, Noone AM, Krapcho M, et al (2014). SEER cancer statistics review, 1975-2011, national cancer institute, Bethesda, MD.
19. Jong KE, Smith DP, Yu XQ, et al (2004). Remoteness of residence and survival from cancer in New South Wales. Med J Aust, 180, 618-22.
20. Jorgensen OD, Kronborg O, Fenger C (2002). A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut, 50, 29-32.
21. Kronborg O, Fenger C, Olsen J, et al (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71.
22. Kronborg O, Fenger C, Sondergaard O, et al (1987). Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol, 22, 677-86.
23. Luke CG, Koczwara B, Moore JE, et al (2005). Treatment and survival from colorectal cancer: the experience of patients at South Australian teaching hospitals between 1980 and 2002. Clin Oncol (R Coll Radiol), 17, 372-81.
24. Mandel JS, Church TR, Bond JH, et al (2000). The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med, 343, 1603-7.
25. (NCCI) National Cancer Control Initiative (2000). The national colorectal cancer care survey. Australian clinical practice in 2000, Clinical Governance Unit, Melbourne.
26. Neo EL, Beeke C, Price T, et al (2011). South Australian clinical registry for metastatic colorectal cancer. ANZ J Surg, 81, 352-7.
27. (NHMRC) National Health and Medical Research Council (1999). Clinical practice guidelines. prevention, early detection and management of colorectal cancer, Commonwealth of Australia, Canberra.
28. Padman S, Padbury R, Beeke C, et al (2013). Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy. Acta Oncol, 52, 1699-706.
29. Ries LAG, Miller BA, Hankey BF, et al (1994). SEER Cancer Statistics Review, 1973-1991, National Cancer Institute, Bethesda, MD.
30. Roder D (2014). What roles should population-based cancer registries be playing in the 21st century? Reflections on the Asian Cancer Registry Forum, Bangkok, February 2014. Asian Pac J Cancer Prev, 15, 1895-6.
31. Roder D, Buckley E (2015). Translation from clinical trials to routine practice: How to demonstrate community benefit. Asia Pac J Clin Oncol, [Epub ahead of print].
32. Roder DM, Fong KM, Brown MP, et al (2014). Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia. Eur J Cancer Care, 23, 721-7.
33. (SACR) South Australian Cancer Registry (1999). Epidemiology of Cancer in South Australia. Incidence, mortality, and survival 1977 to 1998. Incidence and mortality 1998, analysed by type and geographical location. Epidemiology Branch, Department of Health, Adelaide.
34. (SACR) South Australian Cancer Registry (2007). Cancer in South Australia 2004, with incidence projections to 2007, epidemiology branch, department of health, Adelaide.
35. Schmoll HJ, Van Cutsem E, Stein A, et al (2012). ESMO consensus guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol, 23, 2479-516.
36. Scholefield JH, Moss S, Sufi F, et al (2002). Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut, 50, 840-4.
37. STATA (2012). Data analysis and statistical software, Ver. 12, StataCorp LP, college station, Texas.
38. Taheri N, Fazel A, Mahmoodzadeh H, et al (2014). Epidemiology of female reproductive cancers in Iran: results of the Gholestan population-based cancer registry. Asian Pac J Cancer Prev, 15, 8779-82.
39. U.S. Department of Health and Human Services, National Institutes of Health (NIH) (1990). NIH Consensus Development Program: Adjuvant Therapy for Patients with Colon and Rectum Cancer, NIH Consensus Statement Online. April 16-18 1990, 1-25.